Arrowhead Pharmaceuticals Inc
NASDAQ:ARWR

Watchlist Manager
Arrowhead Pharmaceuticals Inc Logo
Arrowhead Pharmaceuticals Inc
NASDAQ:ARWR
Watchlist
Price: 65.545 USD -0.58%
Market Cap: 8.9B USD

Wall Street
Price Targets

ARWR Price Targets Summary
Arrowhead Pharmaceuticals Inc

Wall Street analysts forecast ARWR stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ARWR is 63.083 USD with a low forecast of 17.17 USD and a high forecast of 105 USD.

Lowest
Price Target
17.17 USD
74% Downside
Average
Price Target
63.083 USD
4% Downside
Highest
Price Target
105 USD
60% Upside
Arrowhead Pharmaceuticals Inc Competitors:
Price Targets
ADCT
ADC Therapeutics SA
121% Upside
RXRX
Recursion Pharmaceuticals Inc
52% Upside
ZBIO
Zenas Biopharma Inc
126% Upside
AZT
Arcticzymes Technologies ASA
42% Upside
NVAX
Novavax Inc
50% Upside
ADMA
ADMA Biologics Inc
48% Upside
9926
Akeso Inc
40% Upside
OCGN
Ocugen Inc
381% Upside

Revenue
Forecast

Revenue Estimate
Arrowhead Pharmaceuticals Inc

For the last 13 years the compound annual growth rate for Arrowhead Pharmaceuticals Inc's revenue is 100%. The projected CAGR for the next 3 years is -12%.

100%
Past Growth
-12%
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Arrowhead Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
8%
Average Beat

Net Income
Forecast

Net Income Estimate
Arrowhead Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-39%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ARWR's stock price target?
Price Target
63.083 USD

According to Wall Street analysts, the average 1-year price target for ARWR is 63.083 USD with a low forecast of 17.17 USD and a high forecast of 105 USD.

What is Arrowhead Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
-12%

For the last 13 years the compound annual growth rate for Arrowhead Pharmaceuticals Inc's revenue is 100%. The projected CAGR for the next 3 years is -12%.

Back to Top